期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

左心室辅助装置逆转心衰病理改变的分子机制研究进展

The molecular mechanism research of left ventricular assist device reversing pathological changes of heart failure
下载PDF
导出
摘要 随着生活水平的提高和寿命的延长，心力衰竭在中国的发病率成逐年上升趋势。目前临床上心衰诊断一经确定，5年内的死亡率超过60％，终末期心衰患者预后更差，即使经过药物治疗，1年内的死亡率仍达75％。随着疾病进展，心脏对药物治疗的反应不断减弱，因此疾病后期，供临床医生选择的有效治疗手段十分有限，患者的生存率和生活质量受到很大影响。
作者 成兴华 万峰
机构地区 北京大学第三医院心血管外科
出处 《中国心血管病研究》 CAS 2012年第5期389-393,共5页 Chinese Journal of Cardiovascular Research
关键词 心力衰竭 左心室辅助装置 心室重构 Heart failure Left ventricular assist device Ventricular remodeling
分类号 R654.2 [医药卫生—外科学]
  • 相关文献

参考文献48

  • 1杨水祥,胡大一.心力衰竭的新机制和新策略研究进展[J].中国心血管病研究,2005,3(6):403-405. 被引量：53
  • 2Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med, 2001,345 : 1435-1443.
  • 3Jessup M, Brozena S. Heart failure. N Engl J Med, 2003,348: 2007-2018.
  • 4Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coil Cardiol,2009,54:312-321.
  • 5Rogers JG, Aaronson KD, Boyle A J, et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol, 2010,55 : 1826-1834.
  • 6Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventficular assist device. N Engl J Med, 2009,361 : 2241-2251.
  • 7Baba HA, Wohlsehlaeger J. Morphological and molecular changes of the myocardium after left ventricular mechanical support. Curr Cardiol Rev, 2008,4 : 157-169.
  • 8Dandel M, Weng Y, Siniawski H, et al. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation,2005,112:137-145.
  • 9Zafeiridis A, Jeevanandam V, Houser SR, et al. Regression of eellular hypertrophy after left ventricular assist device support. Circulation, 1998,98 : 656-662.
  • 10Altemose GT, Gritsus V, Jeevanandam V, et al. Altered my- ocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant, 1997,16 : 765-773.

二级参考文献117

  • 1[17]Xiao RP, Ji X, Lakatta EG. Functional coupling of the β2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol 1995; 47:322-329.
  • 2[18]Xiao RP, Avdonin P, Zhou YY, Cheng H, Akhter SA,Eschenhagen T, Lefkowitz RJ, Koch WJ, Lakatta EG. Coupling of β2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res 1999; 84:43-52.
  • 3[19]Kilts JD, Gerhardt MA, Richardson MD, Sreeram G, Mackensen GB, Grocott HP, White WD, Davis RD, Newman MF, Reves JG, Schwinn DA, Kwatra MM. β2-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both Gs and Gi. Circ Res 2000; 87:705-709.
  • 4[20]Xiao RP, Tomhave ED, Wang DJ, Ji X, Boluyt MO, Cheng H, Lakatta EG, Koch WJ. Age-associated reductions in cardiac β1- and β2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest 1998;101:1273-1282.
  • 5[21]Jo SH, Leblais V, Wang PH, Crow MT, Xiao RP. Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent Gs signaling during β2-adrenergic stimulation. Circ Res 2002; 91:46-53.
  • 6[22]Klauck TM, Faux MC, Labudda K, Langeberg LK, Jaken S,Scott JD. Coordination of three signaling enzymes by AKAP79, a mammalian scaffold protein. Science 1996; 271:1589-1592.
  • 7[23]Fink MA, Zakhary DR, Mackey JA, Desnoyer RW, AppersonHansen C, Damron DS, Bond M. AKAP-mediated targeting of protein kinase A regulates contractility in cardiac myocytes. Circ Res 2001; 88:291-297.
  • 8[24]Shih M, Lin F, Scott JD, Wang HY, Malbon CC. Dynamic complexes of β2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem 1999;274:1588-1595.
  • 9[25]Lin F, Wang H, Malbon CC. Gravin-mediated formation of signaling complexes in β2-adrenergic receptor desensitization and resensitization. J Biol Chem 2000; 275:19025-19034.
  • 10[26]Fan G, Shumay E, Wang H, Malbon CC. The scaffold protein gravin (cAMP-dependent protein kinase-anchoring protein 250) binds the β2-adrenergic receptor via the receptor cytoplasmic Arg-329 to Leu-413 domain and provides a mobile scaffold during desensitization. J Biol Chem 2001; 276:24005-24014.

共引文献85

中国心血管病研究
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部